← Back

Pharma & biotech

16 names · 11 named directly by the news · 14 affected

FBRXForte Biosciences76.99 0.00%
1 direct
▼FBRX 8-K — Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Listing Rule · Departure or Election of Directors or Officers
AMGNAmgen377.35 -1.34%
4 direct2 2nd-order
▲AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
MRNAModerna143.97 +5.38%
2 direct
▲The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
AZNAstraZeneca160.17 +0.33%
1 direct
▲HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China
PFEPfizer27.72 +0.25%
2 direct2 2nd-order
▲FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
BMYBristol Myers Squibb63.64 -0.17%
3 direct1 2nd-order
▲Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
MRKMerck143.93 -0.54%
4 direct1 2nd-order
▲MRK 8-K — Results of Operations and Financial Condition
JNJJohnson & Johnson265.58 -0.29%
1 direct
▲These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them
LLYEli Lilly1115.7 -0.65%
3 direct2 2nd-order
▲10% Move Ahead? Ross Gerber Reveals What He's Buying Now
GILDGilead143.72 -0.75%
1 direct
▼FDA Grants Accelerated Approval to a New Breast Cancer Treatment
ABBVAbbVie257.12 +0.83%
1 direct
▲How Much Dividend Income Can You Buy With $250,000?
BIIBBiogen217.15 +0.80%
1 2nd-order
▲FDA Approves First Drug to Treat Alexander Disease
REGNRegeneron781.49 -1.48%
1 2nd-order
▼AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
NVONovo Nordisk43.07 -2.14%
2 2nd-order
▼10% Move Ahead? Ross Gerber Reveals What He's Buying Now
VRTXVertex Pharmaceuticals515.44 +0.17%
—
—
ZTSZoetis72.97 +0.15%
—
—

Stock	Price	News impact	Strongest story
FBRX Forte Biosciences	76.99 0.00%	1 direct	▼FBRX 8-K — Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Listing Rule · Departure or Election of Directors or Officers
AMGN Amgen	377.35 -1.34%	4 direct2 2nd-order	▲AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
MRNA Moderna	143.97 +5.38%	2 direct	▲The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
AZN AstraZeneca	160.17 +0.33%	1 direct	▲HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China
PFE Pfizer	27.72 +0.25%	2 direct2 2nd-order	▲FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
BMY Bristol Myers Squibb	63.64 -0.17%	3 direct1 2nd-order	▲Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
MRK Merck	143.93 -0.54%	4 direct1 2nd-order	▲MRK 8-K — Results of Operations and Financial Condition
JNJ Johnson & Johnson	265.58 -0.29%	1 direct	▲These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them
LLY Eli Lilly	1115.7 -0.65%	3 direct2 2nd-order	▲10% Move Ahead? Ross Gerber Reveals What He's Buying Now
GILD Gilead	143.72 -0.75%	1 direct	▼FDA Grants Accelerated Approval to a New Breast Cancer Treatment
ABBV AbbVie	257.12 +0.83%	1 direct	▲How Much Dividend Income Can You Buy With $250,000?
BIIB Biogen	217.15 +0.80%	1 2nd-order	▲FDA Approves First Drug to Treat Alexander Disease
REGN Regeneron	781.49 -1.48%	1 2nd-order	▼AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
NVO Novo Nordisk	43.07 -2.14%	2 2nd-order	▼10% Move Ahead? Ross Gerber Reveals What He's Buying Now
VRTX Vertex Pharmaceuticals	515.44 +0.17%	—	—
ZTS Zoetis	72.97 +0.15%	—	—

Quotes are delayed. News impact decays over each event's persistence window and drops out when it expires; this page is for ranking at a glance — exact counts live on the stock page.

← All industries